about
Investigation of serum proteome alterations in human glioblastoma multiforme.Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead.The application of SELDI-TOF-MS in clinical diagnosis of cancersPotential serum biomarkers for glioblastoma diagnostic assessed by proteomic approaches.Identification of serum proteomic biomarkers for early porcine reproductive and respiratory syndrome (PRRS) infectionExtracellular vesicles as prospective carriers of oncogenic protein signatures in adult and paediatric brain tumours.Multi-study integration of brain cancer transcriptomes reveals organ-level molecular signaturesProgress in mining the human proteome for disease applicationsThe C-terminal fragment of prostate-specific antigen, a 2331 Da peptide, as a new urinary pathognomonic biomarker candidate for diagnosing prostate cancer.Proteomic analysis of glioma chemoresistance.An Eighteen Serum Cytokine Signature for Discriminating Glioma from Normal Healthy Individuals.Protein expression in dairy cows with and without subclinical hypocalcaemia.Advances in the proteomic discovery of novel therapeutic targets in cancer.Proteomic analysis of cerebrospinal fluid: toward the identification of biomarkers for gliomas.Towards developing biomarkers for glioblastoma multiforme: a proteomics view.Apoptosis-related gene expression in glioblastoma (LN-18) and medulloblastoma (Daoy) cell lines.A specific miRNA signature in the peripheral blood of glioblastoma patients.Design and use of biomarkers for the current and future clinical management of brain tumors.Serum GFAP autoantibody as an ELISA-detectable glioma marker.Proteomic approaches in biomarker discovery: new perspectives in cancer diagnostics.Identification of blood biomarkers in glioblastoma by SWATH mass spectrometry and quantitative targeted absolute proteomics.Proteomic analysis of rat serum revealed the effects of chronic sleep deprivation on metabolic, cardiovascular and nervous system
P2860
Q31063977-D61CAA1C-B667-4013-BCE8-8F9115D7E173Q33891197-5106F73C-47F1-48BC-9EB2-E377630603F8Q33936575-0E008D3A-81F1-4E59-98FD-51D9F94B55CAQ34305848-644A8EA0-298A-4CBE-8467-9F164D63534BQ34371364-E05E398B-D68A-40C0-B1EF-2D0B7DCB9ED4Q34625129-D8E39452-3482-416E-9B73-FB3D0D3F1149Q34916522-61905E37-0052-4114-8412-C4B82E3B4A8DQ35056154-35D57214-11E0-4744-8F99-5EEC8BB55AADQ35261674-5F2E833F-9473-43E5-B750-D7077BB3C998Q35778723-E050E230-91D4-4C00-93A9-92CE049EBE78Q35781959-3F772E8B-7E58-4820-B6AD-1651209DEF72Q35795276-5AAF893F-DFBC-4746-9B66-17127BE4A282Q37260569-29C8CFCD-ECB2-4EC6-BB66-01179F3B275FQ38208182-A09400DB-24C5-430E-9698-FD52CC41A914Q38239173-73108240-54C3-43D6-8DC4-815F8C68BB4AQ39095859-2D553E15-7C2B-4493-8606-8E002C4266B2Q45256953-A793437D-9155-4BE7-A320-021879BD64BCQ48461183-C5B7E442-307C-4BE8-9B1B-4CCB1FCBA77CQ51066755-65986810-3F3F-479A-B08B-678D2008426BQ54962725-0958F523-5D1E-4CF3-A034-A9A066532A41Q55012452-175D7673-3C95-4753-A944-403823F3E6F6Q58713801-08046C8B-B2AD-4874-A112-A6AE12612987
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Serum proteomics of glioma: methods and applications.
@ast
Serum proteomics of glioma: methods and applications.
@en
type
label
Serum proteomics of glioma: methods and applications.
@ast
Serum proteomics of glioma: methods and applications.
@en
prefLabel
Serum proteomics of glioma: methods and applications.
@ast
Serum proteomics of glioma: methods and applications.
@en
P2093
P2860
P356
P1476
Serum proteomics of glioma: methods and applications.
@en
P2093
Durairaj Mohan Kumar
Kumaravel Somasundaram
Mamatha B Nijaguna
P2860
P304
P356
10.1586/ERM.09.52
P577
2009-10-01T00:00:00Z